Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAP | Q12884 | 13/20 | 0.71 |
| ▸ | PREP | P48147 | 8/20 | 0.71 |
| ▸ | DPP4 | P27487 | 16/20 | 0.65 |
| ▸ | DPP7 | Q9UHL4 | 14/20 | 0.65 |
| ▸ | DPP8 | Q6V1X1 | 12/20 | 0.65 |
| ▸ | DPP9 | Q86TI2 | 11/20 | 0.65 |
| ▸ | PITRM1 | Q5JRX3 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13347225 | 0.86 | FAP (0.73) | FAPPREPDPP4DPP7DPP8 | |
| SCHEMBL8286524 | 0.86 | FAP (0.73) | FAPPREPDPP4DPP7DPP8 | |
| SCHEMBL8249904 | 0.83 | FAP (1.00) | FAPPREPDPP4DPP7DPP8 | |
| SCHEMBL8243719 | 0.83 | FAP (1.00) | FAPPREPDPP4DPP7DPP8 | |
| SCHEMBL8286526 | 0.82 | DPP4 (0.73) | FAPPREPDPP4DPP7DPP8 | |
| SCHEMBL15334846 | 0.81 | DPP4 (0.65) | FAPPREPDPP4DPP7DPP8 | |
| SCHEMBL8286523 | 0.79 | DPP4 (1.00) | FAPPREPDPP4DPP7DPP8 | |
| Hydrochloric Acid SCHEMBL31758343 | 0.78 | DPP4 (0.97) | FAPPREPDPP4DPP7DPP8 | |
| SCHEMBL25890374 | 0.77 | DPP4 (0.72) | FAPPREPDPP4DPP7DPP8 | |
| SCHEMBL21746362 | 0.77 | DPP4 (0.74) | FAPPREPDPP4DPP7DPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160250237-A1 | SOFT PROTEASE INHIBITORS AND PRO-SOFT FORMS THEREOF | BACH BIOSCIENCES, LLC | 2016-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160250237-A1 | SOFT PROTEASE INHIBITORS AND PRO-SOFT FORMS THEREOF | PREP, DPP4, PEPD | FAP 51/4885PREP 1/4885DPP4 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.